AAAAAA
Results: 1-25/51
Authors:
WILLMS B
IDOWU K
HOLST JJ
CREUTZFELDT W
NAUCK MA
Citation: B. Willms et al., OVERNIGHT GLP-1 NORMALIZES FASTING BUT NOT DAYTIME PLASMA-GLUCOSE LEVELS IN NIDDM PATIENTS, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(2), 1998, pp. 103-107
Authors:
NAUCK MA
Citation: Ma. Nauck, GLUCAGON-LIKE-PEPTIDE-1 (GLP-1) - A POTENT GUT HORMONE WITH A POSSIBLE THERAPEUTIC PERSPECTIVE, Acta diabetologica, 35(3), 1998, pp. 117-129
Authors:
SEIFARTH C
BERGMANN J
HOLST JJ
RITZEL R
SCHMIEGEL W
NAUCK MA
Citation: C. Seifarth et al., PROLONGED AND ENHANCED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) AFTER ORAL SUCROSE DUE TO ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE) IN TYPE-2 DIABETIC-PATIENTS, Diabetic medicine, 15(6), 1998, pp. 485-491
Authors:
NAUCK MA
WEBER I
BACH I
RICHTER S
ORSKOV C
HOLST JJ
SCHMIEGEL W
Citation: Ma. Nauck et al., NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 ([7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS, Diabetic medicine, 15(11), 1998, pp. 937-945
Authors:
WISHART JM
HOROWITZ M
MORRIS HA
JONES KL
NAUCK MA
Citation: Jm. Wishart et al., RELATION BETWEEN GASTRIC-EMPTYING OF GLUCOSE AND PLASMA-CONCENTRATIONS OF GLUCAGON-LIKE PEPTIDE-1, Peptides (New York, N.Y. 1980), 19(6), 1998, pp. 1049-1053
Authors:
NAUCK MA
SAUERWALD A
RITZEL R
HOLST JJ
SCHMIEGEL W
Citation: Ma. Nauck et al., INFLUENCE OF GLUCAGON-LIKE PEPTIDE 1 ON FASTING GLYCEMIA IN TYPE-2 DIABETIC-PATIENTS TREATED WITH INSULIN AFTER SULFONYLUREA SECONDARY FAILURE, Diabetes care, 21(11), 1998, pp. 1925-1931
Authors:
HEIMESAAT MM
KLAMANN A
SARFERT P
SCHMIEGEL WH
NAUCK MA
Citation: Mm. Heimesaat et al., PREDICTORS OF A LETHAL OUTCOME OF MYOCARDIAL INFARCTIONS IN PATIENTS WITH TYPE 2-DIABETES MELLITUS, Diabetologia, 41, 1998, pp. 479-479
Authors:
RITZEL R
SCHULTE M
NAUCK M
MARZ W
PORKSEN N
SCHMIEGEL W
NAUCK MA
Citation: R. Ritzel et al., GLP-1 INCREASES SECRETORY BURST MASS OF PULSATILE INSULIN-SECRETION IN PATIENTS WITH IMPAIRED GLUCOSE-TOLERANCE AND TYPE-2 DIABETES, Diabetologia, 41, 1998, pp. 710-710
Authors:
NAUCK MA
SARFERT P
KLAMANN A
LAUNHARDT V
SCHULTE G
SCHMIEGEL WH
Citation: Ma. Nauck et al., MYOCARDIAL-INFARCTION IN DIABETIC-PATIENTS - RELATION OF SURVIVAL ANDINFARCT SIZE TO GLIBENCLAMIDE THERAPY, Diabetes, 47, 1998, pp. 477-477
Authors:
NAUCK MA
HOLST JJ
WILLMS B
SCHMIEGEL W
Citation: Ma. Nauck et al., GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AS A NEW THERAPEUTIC APPROACH FOR TYPE-2-DIABETES, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 105(4), 1997, pp. 187-195
Authors:
DREWES C
NAUCK MA
HORN R
HOLST J
SCHMIEGEL W
BRABANT G
Citation: C. Drewes et al., A LIQUID MIXED MEAL OR EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1) DO NOT ALTER PLASMA LEPTIN CONCENTRATIONS IN HEALTHY-VOLUNTEERS, Acta diabetologica, 34(3), 1997, pp. 230-234
Authors:
NAUCK MA
NIEDEREICHHOLZ U
ETTLER R
HOLST JJ
ORSKOV C
RITZEL R
SCHMIEGEL WH
Citation: Ma. Nauck et al., GLUCAGON-LIKE PEPTIDE-1 INHIBITION OF GASTRIC-EMPTYING OUTWEIGHS ITS INSULINOTROPIC EFFECTS IN HEALTHY HUMANS, American journal of physiology: endocrinology and metabolism, 36(5), 1997, pp. 981-988
Authors:
PFEFFER F
NAUCK MA
BENZ S
GWODZINSKI A
ERB M
HOPT UT
Citation: F. Pfeffer et al., PREDICTION OF GLUCOSE-TOLERANCE WITH GLUCAGON STIMULATION IN PANCREASTRANSPLANTED PATIENTS, Transplantation proceedings, 29(7), 1997, pp. 3122-3123
Authors:
PFEFFER F
NAUCK MA
ERB M
BENZ S
HOPT UT
Citation: F. Pfeffer et al., ABSENCE OF SEVERE HYPERINSULINEMIA AFTER PANCREAS KIDNEY TRANSPLANTATION WITH PERIPHERAL VENOUS DRAINAGE/, Transplantation proceedings, 29(1-2), 1997, pp. 645-646
Authors:
NAUCK MA
HOLST JJ
WILLMS B
Citation: Ma. Nauck et al., GLUCAGON-LIKE PEPTIDE-1 AND ITS POTENTIAL IN THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Hormone and Metabolic Research, 29(9), 1997, pp. 411-416
Authors:
NAUCK MA
KEMMERIES G
GROSSER S
ORSKOV C
HOLST JJ
SCHMIEGEL W
Citation: Ma. Nauck et al., RAPID TACHYPHYLAXIS FOR THE DECELERATION OF GASTRIC-EMPTYING BY EXOGENOUS GLP-1, Gastroenterology, 112(4), 1997, pp. 797-797
Authors:
NAUCK MA
BAUM F
SEIDENSTICKER F
RODER M
DINESEN B
CREUTZFELDT W
Citation: Ma. Nauck et al., A HYPERINSULINEMIC, SEQUENTIALLY EU-GLYCEMIC AND HYPOGLYCEMIC CLAMP TEST TO CHARACTERIZE AUTONOMOUS INSULIN-SECRETION IN PATIENTS WITH INSULINOMA, European journal of clinical investigation, 27(2), 1997, pp. 109-115
Authors:
HOLST JJ
GROMADA J
NAUCK MA
Citation: Jj. Holst et al., THE PATHOGENESIS OF NIDDM INVOLVES A DEFECTIVE EXPRESSION OF THE GIP RECEPTOR, Diabetologia, 40(8), 1997, pp. 984-986
Authors:
SAUERWALD A
NAUCK MA
HOLST JJ
SCHMIEGEL WH
Citation: A. Sauerwald et al., INFLUENCE OF GLUCAGON-LIKE PEPTIDE-1 ON FASTING GLYCEMIA IN NIDDM PATIENTS TREATED BY INSULIN (SULFONYLUREA FAILURE), Diabetologia, 40, 1997, pp. 173-173
Authors:
DREWES C
LEU J
HOLST JJ
SCHMIEGEL WH
NAUCK MA
Citation: C. Drewes et al., IMPAIRED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 AFTER ORAL GLUCOSE IN ACROMEGALIC AND GH-DEFICIENT PATIENTS, Diabetologia, 40, 1997, pp. 499-499
Authors:
SEIFARTH C
BERGMANN J
HOLST JJ
RITZEL R
SCHMIEGEL W
NAUCK MA
Citation: C. Seifarth et al., INFLUENCE OF ACARBOSE ON GLP-1 RELEASE AFTER A SUCROSE LOAD IN NIDDM PATIENTS, Diabetologia, 40, 1997, pp. 509-509
Authors:
CREUTZFELDT WOC
ORSKOV C
KLEINE N
HOLST JJ
WILLMS B
NAUCK MA
Citation: Woc. Creutzfeldt et al., GLUCAGONOSTATIC ACTIONS AND REDUCTION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE I(7-36) AMIDE IN TYPE-I DIABETIC-PATIENTS, Diabetes care, 19(6), 1996, pp. 580-586
Authors:
NAUCK MA
BLIETZ RW
QUALMANN C
Citation: Ma. Nauck et al., COMPARISON OF HYPERINSULINEMIC CLAMP EXPERIMENTS USING VENOUS, ARTERIALIZED VENOUS OR CAPILLARY EUGLYCEMIA, Clinical physiology, 16(6), 1996, pp. 589-602
Authors:
NAUCK MA
SIEMSGLUSS J
ORSKOV C
HOLST JJ
Citation: Ma. Nauck et al., RELEASE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1 [7-36-AMIDE]), GASTRIC-INHIBITORY POLYPEPTIDE (GIP) AND INSULIN IN RESPONSE TO ORAL GLUCOSE AFTERUPPER AND LOWER INTESTINAL RESECTIONS, Zeitschrift fur Gastroenterologie, 34(3), 1996, pp. 159-166
Authors:
RODER ME
VISSING H
NAUCK MA
Citation: Me. Roder et al., HYPERPROINSULINEMIA IN A 3-GENERATION CAUCASIAN FAMILY DUE TO MUTANT PROINSULIN (ARG(65)-]HIS) NOT ASSOCIATED WITH IMPAIRED GLUCOSE-TOLERANCE - THE CONTRIBUTION OF MUTANT PROINSULIN TO INSULIN BIOACTIVITY, The Journal of clinical endocrinology and metabolism, 81(4), 1996, pp. 1634-1640